Chiba, Japan

Youichiro Ogawa

This inventor holds 2 USPTO granted patents. Top assignee: Ss Pharmaceutical Co., Ltd.. Active years: 1983-1984.


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 1983-1984

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Youichiro Ogawa: Innovator in Thiazinobenzimidazole Derivatives

Introduction

Youichiro Ogawa is a notable inventor based in Chiba, Japan. He has made significant contributions to the field of medicinal chemistry, particularly through his work on thiazinobenzimidazole derivatives. With a total of 2 patents, Ogawa's innovations are aimed at improving treatments for circulatory system disorders.

Latest Patents

Ogawa's latest patents focus on novel thiazinobenzimidazole derivatives. These derivatives are represented by a general formula that includes various substituent groups. The preparation methods involve reacting 2-hydroxymethyl thiazinobenzimidazole derivatives with reactive derivatives of carboxylic acid or halogenides. Additionally, the derivatives can be synthesized by reacting 2-p-toluenesulfonyloxymethyl-thiazinobenzimidazole derivatives with sodium azides, thiols, phenols, or amines. The thiazinobenzimidazole derivatives are particularly useful as medicaments for circulatory systems.

Career Highlights

Ogawa is currently associated with Ss Pharmaceutical Co., Ltd., where he continues to innovate in the field of pharmaceuticals. His work has been instrumental in developing new therapeutic agents that address critical health issues.

Collaborations

Some of his notable coworkers include Hiromichi Eto and Teruo Kohmoto. Their collaborative efforts have contributed to the advancement of research and development in their field.

Conclusion

Youichiro Ogawa's contributions to the development of thiazinobenzimidazole derivatives highlight his role as a key innovator in medicinal chemistry. His work continues to pave the way for new treatments in the medical field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…